Evidence map›Paper›PMID 22958359›Full record

ArticleMultidisciplinary respiratory medicine2012

The sarcoid granuloma: 'epithelioid' or 'lymphocytic-epithelioid' granuloma?

Zdravko Kosjerina, Bojan Zaric, Dejan Vuckovic, Dusan Lalosevic, Goran Djenadic, Bruno Murer

Open access · goldAbstract read
In one paragraph

Article in Multidisciplinary respiratory medicine, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Article
  3. Innate and Adaptive Immunity in Noninfectious Granulomatous Lung Disease.Journal of immunology (Baltimore, Md. : 1950) · 2022
    Review
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Zdravko KosjerinaPathology Department, Institute for Lung Diseases of Vojvodina, 21234, Sremska Kamenica, Serbia. kosjerina55@yahoo.com.
Bojan Zaric
Dejan Vuckovic
Dusan Lalosevic
Goran Djenadic
Bruno Murer
Institute for Pulmonary Diseases of Vojvodina · RSOspedale dell' Angelo · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThis study aims to analyze the structure and quantities of cellular elements in sarcoid granulomas.

methodsWe investigated 34 transbronchial lung biopsy samples obtained from 34 sarcoid patients. The quantity and composition of the cellular elements inside a granuloma were determined by the quantitative stereometry method, employing the numerical density as a stereological method.

resultsA total of 102 sarcoid granulomas were analyzed. The central part of all granulomas was occupied by epithelioid cells. Besides these, giant cells, lymphocytes, macrophages and plasma cells were also seen. The mean numerical density of all the cells in the central part of a sarcoid granuloma was 111,751 mm-3. Lymphocytes prevailed in number, exceeding the total count of all other cells. With a mean numerical density of 74,321 mm-3, lymphocytes were twice as numerous as both epithelioid cells and macrophages with a mean numerical density of 37,193 mm-3.

conclusionsLymphocytes are the predominant cell type in the central part of a sarcoid granuloma, significantly exceeding both epithelioid cells and macrophages in number, raising the question if the term "epithelioid granuloma", routinely used to designate sarcoid granulomas, is correct, or if it would be more logical to call them "lymphocytic-epithelioid granulomas" instead.

trial registrationThis study was supported by the Serbian Ministry of Science and Environmental Protection Grant Number 175006/2011.

Identifiers

PMID22958359
PMCPMC3436643
OpenAlexW2111379047

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.